Aries TCO Announces Launch of ACE and SIERA - Revolutionary

New Post Public Reply Private Reply Replies (0) Message Board
News Desk 2018
Aries TCO Announces Launch of ACE and SIERA - Revolutionary Business Technologies

PALM BEACH GARDENS, Fla., Sept. 23, 2014 (GLOBE NEWSWIRE) -- via PRWEB - After seven years of development, Aries TCO is excited to announce they have released two powerful business solutions, ACE and SIERA , which will benefit companies of all sizes. These systems are designed to help businesses operate more efficiently and profitably by providing real-time insights into their operations, as well as enabling them to deliver their IT projects to the market quicker.

ACE is essentially a robot programmer that generates code to a point of 95% or greater completion, thus reducing the amount of time and number of programmers required to complete a project. It also offers dramatically increased levels of quality, standardization, and consistency desired from any code base in an organization, and enables customers to rapidly create, maintain, and enhance any software system. This intelligence can also be leveraged in the execution of complex large scale ETL (Extract, Transform, Load) projects. According to Aries TCO founder Paiman Allage, "Although we originally created ACE for our own use, we recognized it could offer great value to any business by helping them deliver IT projects on budget, in a fraction of the time, and with higher quality."

In addition to ACE, Aries TCO also released SIERA, a highly advanced ERP program, and the only system on the market today that is process driven. This permits businesses to operate the way they want to, as opposed to conforming to the technology as most other programs require. SIERA features more than 25 functional modules, and allows business owners to customize a solution that best meets their needs. Some of the key benefits provided by this software solution include:

  • Centralization of information and processes
  • Analytics
  • Intelligent relationships between data and real-time business monitoring
  • Rapid integration with other systems
  • Process focused (rather than feature focused)
Anyone who would like to learn about ACE and SIERA and what they can do for their business can find out more by visiting the Aries TCO website or by calling 1-877-262-2830. Also, Aries is offering attractive discounts on SIERA and ACE on their Indiegogo campaign. Any one interested should visit http://www.indiegogo.com/projects/aries-tco-inc to get a deal on SIERA and ACE.

About Aries TCO: Florida-based tech company, Aries TCO, focuses on helping businesses put technology to work for them. Founder Paiman Allage created the company in 2007 to develop an easy way to implement programs businesses need to function. Their mission is to set companies free from the rigors of programming and technology so they can focus on their core operations. Aries TCO specializes in Microsoft based systems and platforms and works with a variety of technologies, including MySQL, AJAX, PHP, Silverlight and others.

This article was originally distributed on PRWeb. For the original version including any supplementary images or video, visit http://www.prweb.com/releases/2014/09/prweb12189693.htm

Aries TCO, Inc. Paiman Allage +1 561 2281701

Scroll down for more posts ▼

Top 10 Most Recent News Articles

PANDAG G1 Debuts: Revolutionizing Lawn Care Efficiency

Updated Category News Views 4

The Future of Landscaping Unveiled Get this—PANDAG is set to shake things up at GaLaBau 2026 with their futuristic G1 autonomous mower. This isn't just another piece of lawn equipment; it's practically a tech marvel on wheels, weaving together LiDAR, AI Vision, RTK, and 4G tech to make it the ultimate multitasker for the landscaping industry. We're talking obstacle...

Continue Reading
Regeneron Faces Legal Heat: Lead Plaintiff Deadline Looms

Updated Category News Views 3

Regeneron’s Tight Spot: Legal Showdown Well, here we go again—Regeneron Pharmaceuticals (NASDAQ:REGN) is under some serious heat. If you're an investor who faced significant losses with this biotech juggernaut, remember that the clock’s ticking down to the wire. By tomorrow, September 14, 2026, you need to decide if you're going to throw your hat in the ring for...

Continue Reading
Tam-Peli Steps Up in SCLC Battle: Trial Insights

Updated Category News Views 5

Noteworthy Developments in Small-Cell Lung Cancer Treatment Let's dive into a story straight from the world of small-cell lung cancer (SCLC) that doesn't take any prisoners. The antidote making waves is tambotatug pelitecan, or Tam-Peli for short, showcasing its might in the unrelenting fight against relapsed SCLC. The phase III TAISHAN-302 trial puts Tam-Peli...

Continue Reading
Surfing Dogs Ride Waves, Support Orphan Pets

Updated Category News Views 3

Waves, Paws, and Passion Who would've thought that dogs catching waves could also catch hearts and wallets? Well, that's exactly what's happening today at Del Mar Dog Beach with the 21st Annual Surf Dog Surf-A-Thon revving up the excitement. It's a sun-soaked day in Rancho Santa Fe, California, right in the thick of things at the longest-running dog surf competition. For...

Continue Reading
MRI Surveillance Gains Ground in Lung Cancer Care

Updated Category News Views 6

Shifting the Standard: MRI's Rise in SCLC Treatment Here's a twist that baffles the traditionalists—ditch the prophylactic cranial irradiation (PCI) and catch clearer days with MRI surveillance for small-cell lung cancer (SCLC). The latest international phase III MAVERICK trial might just redraw the lines on what's considered standard care in this relentless disease....

Continue Reading
First-Time Homeowners: Unseen Pitfalls of Insurance

Updated Category News Views 3

Understanding Homeowners Insurance: Beyond the Basics Most folks diving into homeownership for the first time get caught up in the whirlwind of price tags, loans, and knick-knacks for their new place. Meanwhile, the nitty-gritty of homeowners insurance often gets tossed to the side. But take it from a weary watchdog of financial storms—it’s those details in the policy...

Continue Reading
Ris-Rez May Set New Standard in Relapsed SCLC

Updated Category News Views 6

The Game-Changing Results Innovation in pharmaceuticals sometimes feels like a waiting game, but when a fresh breakthrough like this rolls in, it lights up the whole landscape. Risvutatug rezetecan, or Ris-Rez for short, has shown promising potential in the fight against relapsed small-cell lung cancer (SCLC) that has progressed after platinum-based therapy. Survival...

Continue Reading
PwC US and India Unite for Global Consultancy Powerhouse

Updated Category News Views 6

Rearranging the Consultancy Chessboard Piling onto the game of consultancy realignments, PwC just made a move reminiscent of playing strategy poker. They're tossing together PwC US and PwC India's advisory capabilities for a new joint venture. It’s like pushing two puzzle pieces to make a single colorful picture that stretches from the U.S. all the way to the...

Continue Reading
UWM Faces Class Action Deadline: Key Insights for Investors

Updated Category News Views 2

The High Stakes Reality for UWM Investors If there's one thing that's certain in this jittery world of investing, it's that losses have a way of waking you up. Right now, anyone tied up with UWM Holdings Corporation (NYSE: UWMC) shares needs to keep their wits about them; we're barreling toward an October 13, 2026 deadline for a class action lawsuit. The clock's ticking...

Continue Reading
Trial Disappointment: No Significant Gains in NSCLC

Updated Category News Views 12

Dissecting the Nuances of the EVOKE-03/KEYNOTE-D46 Trial Every once in a while, we come across a trial that rattles cages in the research community. Today, it's the EVOKE-03/KEYNOTE-D46 trial, a collision of hope and hard-knock reality. This Phase 3 trial, which sought to explore the potential combo of sacituzumab govitecan (SG) and pembrolizumab on metastatic non-small...

Continue Reading
More News Articles